X
API Suppliers
US DMFs Filed
CEP/COS Certifications
0
JDMFs Filed
Other Certificates
Other Suppliers
0
0
USA (Orange Book)
Europe
0
Canada
0
Australia
0
South Africa
0
Uploaded Dossiers
0
U.S. Medicaid
0
Annual Reports
0
0
USFDA Orange Book Patents
USFDA Exclusivities
0
Blog #PharmaFlow
0
News
0
EDQM
0
USP
0
JP
0
Other Listed Suppliers
0
0
Details:
QBREXZA (Rapifort® Wipes 2.5%), is a topical product approved by the U.S. Food and Drug Administration for treatment of primary axillary hyperhidrosis in adult and pediatric populations (ages nine-years and older) and is self-administered by patients.
Lead Product(s): Glycopyrronium Tosylate
Therapeutic Area: Dermatology Product Name: Rapifort Wipes
Highest Development Status: ApprovedProduct Type: Small molecule
Partner/Sponsor/Collaborator: Maruho
Deal Size: $10.0 million Upfront Cash: Undisclosed
Deal Type: Agreement February 11, 2022
Details:
Journey Medical acquired global rights to QBREXZA® from Dermira in 2021. QBREXZA is a topical product approved by the U.S. Food and Drug Administration for treatment of primary axillary hyperhidrosis in adult and pediatric populations.
Lead Product(s): Glycopyrronium Tosylate
Therapeutic Area: Dermatology Product Name: Qbrexza
Highest Development Status: ApprovedProduct Type: Small molecule
Partner/Sponsor/Collaborator: Maruho Co
Deal Size: $7.5 million Upfront Cash: Undisclosed
Deal Type: Agreement February 11, 2022
Details:
QBREXZA is the only topical product to be approved by the U.S. Food and Drug Administration (FDA) for treatment of primary axillary hyperhidrosis in adult and pediatric populations (ages nine-years and older) and is self-administered by patients.
Lead Product(s): Glycopyrronium Tosylate
Therapeutic Area: Dermatology Product Name: Qbrexza
Highest Development Status: ApprovedProduct Type: Small molecule
Partner/Sponsor/Collaborator: Journey Medical Corporation
Deal Size: Undisclosed Upfront Cash: Undisclosed
Deal Type: Acquisition April 01, 2021
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results] 
Market Place
